You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 21, 2025

Details for Patent: 9,861,631


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,861,631 protect, and when does it expire?

Patent 9,861,631 protects MIRVASO and is included in one NDA.

This patent has eighty-eight patent family members in twenty-five countries.

Summary for Patent: 9,861,631
Title:Methods and compositions for safe and effective treatment of erythema
Abstract: Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.3% to about 10% by weight of brimonidine and a pharmaceutically acceptable carrier.
Inventor(s): Graeber; Michael (Lawrenceville, NJ), Loesche; Christian (Hegenheim, FR), Freidenreich; Philip (Yardley, PA), Liu; Yin-sang (Princeton Junction, NJ), Leoni; Matthew James (Titusville, NJ)
Assignee: Galderma Laboratories, L.P. (Fort Worth, TX)
Application Number:14/679,598
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,861,631

Introduction

Patents are a crucial component of intellectual property law, providing inventors and companies with exclusive rights to their innovations. The United States Patent 9,861,631, like any other patent, is subject to a complex set of rules and regulations that define its scope and validity. Here, we will delve into the details of this patent, exploring its claims, the patent landscape, and the implications of recent legal and procedural developments.

What is United States Patent 9,861,631?

To analyze the scope and claims of United States Patent 9,861,631, it is essential to start with the basics. This patent, issued by the U.S. Patent and Trademark Office (USPTO), grants exclusive rights to the patent holder for a specific invention or innovation.

Claim Scope and Drafting

The claim scope is a critical aspect of any patent application. It defines the boundaries of what is protected by the patent. A common misconception is that broader claims are always better, but this is not the case. Broader claims can be more challenging to defend and may be more likely to be invalidated due to prior art or failure to meet the written description requirement[3].

Claim Validity and Invalidation Grounds

Claims in a patent must be anchored to the embodiments disclosed in the specification. Overly broad claims can be invalidated on grounds such as the abstract idea exception or failure to meet the written description requirement. For example, the Federal Circuit has ruled in cases like Yu v. Apple Inc. that claims broader than the specific examples described in the specification can easily fall under the abstract idea exception[3].

Patent Landscape and Prior Art

The patent landscape for any given invention is crucial in determining the validity of a patent's claims. The USPTO provides several tools for searching prior art, including the Patent Public Search tool, Global Dossier, and the Public Search Facility. These resources help in identifying existing patents and published patent applications that could affect the validity of a new patent[4].

Obviousness-Type Double Patenting (ODP)

A significant issue in patent law is obviousness-type double patenting (ODP), which prohibits the issuance of multiple patents for the same invention. Recent court decisions, such as Allergan USA, Inc. v. MSN Laboratories Private Ltd., highlight the complexities of ODP. In this case, the court determined that a claim could be invalidated if it was not patentably distinct from earlier-filed and earlier-issued claims, even if it was the first to be filed and issued[2].

Patent Term and Expiration

The term of a patent is another critical factor. Since the passage of the Uruguay Round Agreements Act of 1994, patent terms are measured from the effective filing or priority date rather than the issuance date. This change affects how patent expiration dates are calculated and can impact the validity and enforceability of claims[2].

International Patent Considerations

In today's globalized world, it is essential to consider international patent landscapes. Databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO) allow inventors to search for prior art and existing patents worldwide. This ensures that a patent is novel and non-obvious on a global scale[4].

Small Claims Patent Court

There is ongoing discussion about the feasibility of a small claims patent court in the U.S., which could simplify and reduce the costs associated with patent litigation. The Administrative Conference of the United States (ACUS) has conducted studies and gathered public comments on this issue, highlighting the potential benefits and challenges of such a court[5].

Practical Implications for Patent Holders

For patent holders, understanding the scope and claims of their patents is vital for enforcement and defense. Here are some key takeaways:

  • Precision in Claim Drafting: Ensure that claims are precisely drafted and anchored to the embodiments in the specification to avoid invalidation.
  • Prior Art Search: Conduct thorough prior art searches using available tools to ensure novelty and non-obviousness.
  • International Considerations: Consider the global patent landscape to ensure that the patent is valid worldwide.
  • Legal Updates: Stay updated with recent legal decisions and changes in patent law, such as those related to ODP and patent term calculations.

Key Takeaways

  • Claim Scope: Broader claims are not always better; they must be anchored to the specification.
  • Prior Art: Thorough searches are essential to ensure novelty and non-obviousness.
  • ODP: Claims must be patentably distinct to avoid invalidation due to ODP.
  • International Landscape: Global searches are crucial for ensuring a patent's validity worldwide.
  • Legal Compliance: Stay updated with legal decisions and changes in patent law.

FAQs

Q: What is the importance of claim scope in a patent application? A: The claim scope defines the boundaries of what is protected by the patent. It must be precisely drafted and anchored to the embodiments in the specification to avoid invalidation.

Q: How does obviousness-type double patenting (ODP) affect patent claims? A: ODP prohibits the issuance of multiple patents for the same invention. Claims must be patentably distinct from earlier-filed and earlier-issued claims to avoid invalidation.

Q: What tools are available for searching prior art in the U.S.? A: The USPTO provides tools such as the Patent Public Search tool, Global Dossier, and the Public Search Facility for searching prior art.

Q: How has the Uruguay Round Agreements Act of 1994 impacted patent terms? A: The act changed how patent terms are calculated, measuring them from the effective filing or priority date rather than the issuance date.

Q: What is the potential benefit of a small claims patent court? A: A small claims patent court could simplify and reduce the costs associated with patent litigation, making it more accessible for smaller inventors and companies.

Sources

  1. U.S. Patent and Trademark Office (USPTO)

    • [USPTO Website][1]
  2. Allergan USA, Inc. v. MSN Laboratories Private Ltd.

    • [Court Decision PDF][2]
  3. The Importance of Getting the Claim Scope Right in a US Patent Application

    • [Rimon Law Article][3]
  4. Search for Patents - USPTO

    • [USPTO Patent Search][4]
  5. U.S. Patent Small Claims Court

    • [ACUS Study][5]

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 9,861,631

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Galderma Labs Lp MIRVASO brimonidine tartrate GEL;TOPICAL 204708-001 Aug 23, 2013 AB RX Yes Yes ⤷  Try for Free ⤷  Try for Free TOPICAL TREATMENT OF FACIAL ERYTHEMA OF ROSACEA ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 1 of 1 entries

International Family Members for US Patent 9,861,631

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
European Patent Office 1631293 ⤷  Try for Free CR 2014 00031 Denmark ⤷  Try for Free
European Patent Office 1631293 ⤷  Try for Free C300683 Netherlands ⤷  Try for Free
European Patent Office 1631293 ⤷  Try for Free 1490049-2 Sweden ⤷  Try for Free
European Patent Office 1631293 ⤷  Try for Free C20140022 00150 Estonia ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.